Eckenstein-Geigy-Stiftung

Leon Nanodrugs is a specialized product development company focused on enhancing existing drug formulations through nanotechnology. The company develops a pipeline of next-generation nano-formulated drugs that improve the bioavailability of poorly water-soluble medications. Utilizing its proprietary MJR® Technology platform, Leon Nanodrugs creates either polymeric or crystalline nanoparticles designed to offer significant differentiation and added benefits for patients. In addition to its drug development efforts, the company provides services that support pre-clinical and clinical stage formulations for clients, including new chemical entities and established branded drugs. Through its innovative approach, Leon Nanodrugs aims to improve patient outcomes in the pharmaceutical industry.

Ampersand is a company based in Kigali, Rwanda, that focuses on manufacturing affordable electric vehicles and charging systems specifically for motorcycle taxi drivers in East Africa. By providing a battery swap network and an operating system, Ampersand aims to make sustainable mobility more accessible and affordable in developing markets. The company's initiatives not only enhance the livelihoods of local drivers but also contribute positively to the environment. As of January 2024, Ampersand has attracted 2,000 customers who collectively travel 1.5 million kilometers weekly in Nairobi and Kigali, illustrating the growing demand for electric mobility solutions in the region.

B-rayZ is a spin-off from the University Hospital Zurich, focused on enhancing radiology through advanced technology. The team comprises experienced radiologists, data scientists, and physicians with over 15 years of expertise in medical imaging. B-rayZ develops artificial intelligence-based software that aids radiologists in mammography by offering real-time assessments of image quality and breast density. This innovative software enables accurate and standardized evaluations of medical imaging data, thereby improving breast cancer detectability. By providing intelligent tools, B-rayZ supports radiologists in enhancing their diagnostic capabilities while also contributing to reduced healthcare costs.

NeoPrediX specializes in developing decision support tools that focus on maternal, neonatal, and perinatal screening. The company’s platform utilizes advanced algorithms and digital health solutions to analyze deep medical data, enabling healthcare professionals to evaluate, optimize, and personalize medical strategies in pediatrics. By transforming complex medical data into actionable insights, NeoPrediX aims to enhance clinical decision-making, thereby improving care for newborns and minimizing the risk of long-term health complications. The solutions are crafted by a team of experienced scientists, pediatricians, and neonatologists, ensuring that the tools are grounded in robust medical science.

Leon Nanodrugs is a specialized product development company focused on enhancing existing drug formulations through nanotechnology. The company develops a pipeline of next-generation nano-formulated drugs that improve the bioavailability of poorly water-soluble medications. Utilizing its proprietary MJR® Technology platform, Leon Nanodrugs creates either polymeric or crystalline nanoparticles designed to offer significant differentiation and added benefits for patients. In addition to its drug development efforts, the company provides services that support pre-clinical and clinical stage formulations for clients, including new chemical entities and established branded drugs. Through its innovative approach, Leon Nanodrugs aims to improve patient outcomes in the pharmaceutical industry.

Viebeg operates a data-driven logistics platform that focuses on medical procurement for healthcare facilities. By utilizing AI technology, Viebeg enhances the efficiency of inventory management, enabling healthcare providers to access affordable medical and dental supplies and equipment. The platform facilitates shipping, warehousing, last-mile distribution, and real-time data analysis, ensuring that healthcare facilities maintain optimal stock levels of essential medical supplies. This comprehensive approach not only streamlines the procurement process but also helps prevent health crises by ensuring timely availability of necessary resources for patient care.

UrbanFarmers specializes in creating urban agriculture systems that integrate aquaponics, allowing for the cultivation of fish and plants in urban environments. The company focuses on developing rooftop farm solutions tailored for commercial growers and food retailers, utilizing unused spaces such as empty buildings and rooftops. By transforming these underutilized areas into productive agricultural sites, UrbanFarmers enables clients to maximize their real estate while contributing to sustainable food production in urban settings.